Le comité de surveillance du risque et de pharmacovigilance de l’Agence européenne du médicament (EMA) rendra, lui, son avis jeudi.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.